Jiuzhitang Co., Ltd. Independent Director 2025 Annual Performance Report (Zhang Quanguo)

Securities Code: 000989 Securities Abbreviation: Jiuzhitang Announcement No.: 2026-020

Jiuzhitang Co., Ltd. Independent Director 2025 Annual Performance Report (Zhang Quanguo)

The Company and the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or significant omissions.

In accordance with the "Administrative Measures for Independent Directors of Listed Companies," "Shenzhen Stock Exchange Main Board Listed Company Regulation No. 1 - Norms for Operation of Main Board Listed Companies," and the "Independent Director System of Jiuzhitang Co., Ltd.," as an independent director of Jiuzhitang Co., Ltd. (hereinafter referred to as the "Company" or "this Company"), during my tenure in 2025, I diligently performed my duties as an independent director, leveraging my professional expertise to provide opinions and suggestions on the Company's operational decisions and standardized operations, and conscientiously safeguarding the interests of the Company and all shareholders. The following is my performance report during my tenure:

I. Basic Information of Independent Directors

1. Basic Information of the Individual Born in April 1964, with a bachelor's degree. Currently serving as an independent director of this Company, assistant president of Xiangcai Co., Ltd., executive director of Heilongjiang HGC Industrial Group Co., Ltd., and formerly executive director of HGC Bai Tian E Pharmaceutical Group Co., Ltd. I graduated from a medical college, possess knowledge in the pharmaceutical field, am familiar with the dynamics of the pharmaceutical industry, and have many years of rich experience in enterprise management, enabling me to provide professional advice to listed companies.

2. Self-Assessment of Independence I do not hold any positions in the Company other than independent director and member of the Board's special committees. I have no direct or indirect interest relationship with the Company or its major shareholders, nor any other relationship that may affect my independent and objective judgment. In performing my duties as an independent director, I am not influenced by the Company, its major shareholders, or any other entity or individual. I confirm that I meet all the independence requirements stipulated by the regulatory provisions for serving as an independent director of a listed company.

II. Overview of Independent Director's Performance in the Reporting Year

1. Number of Board Meetings Attended, Method of Attendance, and Voting Results; Number of Shareholder Meetings Attended During my tenure in 2025, the Company convened 8 Board meetings, all of which I attended in person and voted. The Company convened 4 shareholder meetings, and I attended 2 in person. I carefully reviewed the proposals and relevant materials deliberated by the Board of Directors. I expressed agreement with all proposals deliberated by the Board during the reporting period and did not cast any dissenting or abstention votes.

2. Participation in Special Committees of the Board and Independent Director Special Meetings (1) Board Special Committees In 2025, the Company's Board Strategy Committee convened 1 meeting. I attended the meeting, deliberated on the proposals, and expressed a clear agreement.

(2) Independent Director Special Meetings In 2025, during my tenure as an independent director of Jiuzhitang, the Company convened 1 special meeting for independent directors. I attended the meeting, deliberated on the proposal regarding related-party transactions, and expressed a clear agreement.